EARNINGS: hVIVO CFO to retire; Personal Group sales and profit climb
15th Sep 2026 15:54
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 6.10p on 15-09-2026 at 18:15:13 |
|---|---|
| Change | -0.30p -4.69% |
| Buy | 6.20p |
| Sell | 6.00p |
| Last Trade: | Unknown 408.00 at 6.10p |
| Day's Volume: | 4,621,195 |
| Last Close: | 6.10p |
| Open: | 6.30p |
| ISIN: | GB00B9275X97 |
| Day's Range | 5.85p - 6.30p |
| 52wk Range: | 4.35p - 10.00p |
| Market Capitalisation: | £41.99m |
| VWAP: | 6.023219p |
| Shares in Issue: | 688.40m |
Sector: Health Care and Related Services
Listed In: FTSE AIM 100, FTSE AIM All-Share,
hVIVO (HVO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 408 | 6.10p | Negotiated Trade |
16:37:16 - 15-Sep-26 |
| Sell* | 55,022 | 6.02p | Ordinary |
16:11:23 - 15-Sep-26 |
| Sell* | 77,790 | 6.035p | Ordinary |
16:02:04 - 15-Sep-26 |
| Buy* | 16,110 | 6.164p | Ordinary |
15:44:16 - 15-Sep-26 |
| Sell* | 77,791 | 6.025p | Ordinary |
15:35:13 - 15-Sep-26 |
| Sell* | 15,154 | 6.035p | Ordinary |
15:18:10 - 15-Sep-26 |
| Sell* | 1,661 | 6.01p | Ordinary |
15:17:17 - 15-Sep-26 |
| Buy* | 14,406 | 6.171p | Ordinary |
15:16:56 - 15-Sep-26 |
| Buy* | 10,000 | 6.171p | Ordinary |
15:05:38 - 15-Sep-26 |
| Buy* | 7,000 | 6.171p | Ordinary |
15:03:01 - 15-Sep-26 |
hVIVO (HVO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 15th Sep 2026 7:01 am | RNS | Interim Results |
| 15th Sep 2026 7:00 am | RNS | Chief Financial Officer Succession |
| 8th Sep 2026 3:51 pm | RNS | Holding(s) in Company |
| 4th Sep 2026 7:00 am | RNS | Notice of Results |
| 27th Aug 2026 7:00 am | RNS | hVIVO acquires CRS Berlin |
| 23rd Jul 2026 7:00 am | RNS | H1 2026 Trading Update |
| 13th Jul 2026 7:00 am | RNS | Change of Auditor |
| 9th Jun 2026 7:00 am | RNS | Holding(s) in Company |
| 1st Jun 2026 12:00 pm | RNS-R | Consultancy contract with Decoy Therapeutics |
| 29th May 2026 7:00 am | RNS | Grant of awards under Long Term Incentive Plan |